Quantum Biopharma Ltd.
corporate_fare Company Profile
Quantum Biopharma Ltd. (NASDAQ:QNTM) is a publicly traded company in the Life Sciences sector. Wiseek monitors QNTM SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- FDA Places Lead MS Drug (Lucid-MS) IND on Clinical Hold, Halting Development
- Quantum Biopharma Engages Stocks.news for Investor Relations and Marketing
- Quantum BioPharma's MS Imaging Study with MGH Hits Midpoint, Showing Promising Early Data
- Quantum Biopharma Boosts Liquidity, Files IND for MS Drug Phase 2 Trial, Extends Runway to 2027
- Quantum Biopharma Secures $9.7M in Dilutive Financing Amidst Rising Losses and Negative Equity
Insider Transactions
QNTM files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.